Transforming Drug Development With Statistical Science

Statistical science is playing an increasingly critical role in the transformation of drug development. Modern clinical trials are using advanced statistical methods and computational biology to become more efficient, cost-effective, and ultimately more likely to succeed. This has created a significant impact on both the biopharmaceutical companies that are developing these innovative products and the patients who will benefit from them.

This webinar explores how you can leverage complex innovative trial designs, Bayesian statistics, and artificial intelligence to accelerate development timelines and improve outcomes. Watch this session to learn about the application of biomarkers and pharmacogenomics for patient enrichment and how to use statistical assessments to evaluate drug products' immunogenicity response.